Curve Therapeutics, a pioneering company in drug discovery, has successfully raised a substantial $50 million in a recent funding round, bolstering its mission to revolutionize the development of first-in-class small molecule therapeutics. With a unique focus on expanding the landscape of disease targets that can be effectively drugged, Curve Therapeutics is at the forefront of innovative solutions in cancer treatment. The funding will be instrumental in enhancing their cutting-edge Microcycle® platform, which allows for direct screening of biologically active hits within mammalian cells, thus streamlining the hit-to-lead process. This platform empowers Curve Therapeutics to rapidly identify and develop novel therapeutic candidates that address high-priority cancer targets that have long been considered elusive. The financial support will not only accelerate the advancement of their existing pipeline but also foster further research and development efforts aimed at tackling urgent health challenges faced by cancer patients. As the company continues to pave the way for breakthrough innovations in oncology, the newly acquired funds represent a critical step in their commitment to delivering transformative therapeutics that can significantly improve patient outcomes. With a dedicated team and robust technology, Curve Therapeutics stands poised to make a lasting impact on the pharmaceutical landscape, offering hope to millions affected by cancer.
Curve Therapeutics Secures $50 Million in Series A Funding to Revolutionize Drug Discovery for Cancer Therapeutics
Get the full Curve Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Trackk
At Trackk, we're building a New-Gen trading platform. Designed for speed, precision, and simplicity. From faster trading to insightful analytics, we’re reimagining how the new generation connects with wealth and opportunities.
$3.7M Seed
today
Armada
Welcome to the new edge. Armada is the world’s first full-stack edge computing platform, revolutionizing connectivity, compute, and AI solutions where they’re needed most - anywhere on Earth.
$230.0M Series b
today
bunch
bunch is building the backbone of private markets with an end-to-end platform that enables funds and investors to operate, administer, and transact seamlessly. Designed with GPs at heart, bunch’s data-centric approach ensures GPs and LPs have access to accurate, up-to-date information in one centralized hub, fostering smarter, faster decision-making and transparent collaboration. Privacy Policy: https://www.bunch.capital/privacy-policy
$35.0M Series b
today
Gamehok
We aim to create a comprehensive platform tailored specifically for competitive gamers and streamers. Our goal is to assist gamers in their journey to become professional esports athletes by furnishing them with an optimal practice environment. Concurrently, our platform will empower gamers to cultivate their personal brand and foster a thriving community by facilitating connections and interactions with fellow gamers. Through our platform, we strive to support the growth and development of gamers, enabling them to hone their skills, establish their presence, and engage with a vibrant network of like-minded individuals within the competitive gaming sphere.
$100.0K Pre-seed
today
CRACI
CRACI is solving the upcoming EU Cyber Resilience Act. https://craci.com
$1.4M Pre-seed
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Onramp United States | Series a | $12.5M | 1d ago |
| 2 |  Anomaly United States | Series a | $17.0M | 1d ago |
| 3 |  SugaROx United Kingdom | Series a | $3.4M | 3d ago |
| 4 |  YUZU | Series a | $35.0M | 3d ago |
| 5 |  Optura.AI | Series a | $17.5M | 3d ago |